SCHEMBL6174950

SCHEMBL6174950

CC1(Cc2ccnc3c(N)cccc23)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
AR P10275 4/20 0.34
OPRL1 P41146 1/20 0.34
NTRK1 P04629 1/20 0.34
CTSD P07339 3/20 0.33
BACE1 P56817 3/20 0.33
BACE2 Q9Y5Z0 3/20 0.33
IGF1R P08069 1/20 0.33
TRPV4 Q9HBA0 1/20 0.33
TEAD1 P28347 2/20 0.32
TEAD4 Q15561 2/20 0.32
TEAD2 Q15562 2/20 0.32
TEAD3 Q99594 2/20 0.32
PDE2A O00408 1/20 0.32
ELOVL6 Q9H5J4 1/20 0.32
ELOVL3 Q9HB03 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172285 0.90 MAPK7 (0.39) POLBL3MBTL1ARNTRK1IGF1R
SCHEMBL6171211 0.89 HCRTR1 (0.39) POLBL3MBTL1ALDH1A1CYP3A4GAA
SCHEMBL6171026 0.89 AR (0.35) POLBL3MBTL1ARNTRK1IGF1R
SCHEMBL6171367 0.88 TEAD1 (0.34) POLBL3MBTL1ARNTRK1IGF1R
SCHEMBL6175888 0.88 GRM5 (0.35) POLBL3MBTL1AROPRL1NTRK1
SCHEMBL6172558 0.85 TRPV4 (0.35) POLBL3MBTL1NTRK1TRPV4ELOVL6
SCHEMBL2941483 0.80 IGF1R (0.54) NTRK1IGF1R
SCHEMBL6173958 0.79 AR (0.35) POLBL3MBTL1ARNTRK1IGF1R
SCHEMBL6177158 0.78 BACE1 (0.38) POLBL3MBTL1AROPRL1NTRK1
SCHEMBL6173435 0.78 IGF1R (0.45) POLBL3MBTL1ARNTRK1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed